ARKG Holdings of Verve Therapeutics (VERV) - Updated Daily
Gene TherapyGenomicsCRSPR Gene Editing
Key Statistics
Statistics
⚖️Weighting | 🧢Market Cap |
---|---|
1.54% | $575.30m |
🏋🏿♂️Weight Rank In ARKG | 🌏Country |
25 | 🇺🇸United States |
🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
46 | $37.81 |
🎫ARK Ownership Percent | |
3.61% |
Other ETFs That Hold VERV
Research Notes and Commentary for VERV
No Research Notes Found for VERV